Publication: 3416

Publication: 3416

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Leukemia vol 35 (10) 2854-2861

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: Received

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes
Book Volume:: 11

Parents:: 3251
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Pharmacyclics
Grants:: U10CA180821, U10CA180882, U24CA196171; UG1CA232760, UG1CA233180, UG1CA233253, UG1CA233327, UG1CA233331, R35CA198183, R01CA192928, U10CA180863 (CCTG)

Corr. Author:
Authors:: Amy S. Ruppert Allison M. Booth Wei Ding Nancy L. Bartlett Danielle M. Brander Steven Coutre Jennifer R. Brown Sreenivasa Nattam Richard A. Larson Harry Erba Mark Litzow Carolyn Owen Charles S. Kuzma Jeremy S. Abramson Richard F. Little Scott E. Smith Richard M. Stone John C. Byrd Sumithra J. Mandrekar Jennifer A. Woyach

Networks:: IL017, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, OH070, SCOR

Study: Alliance-A041202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Article